EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo‐Immuno‐Embolization for the Treatment of Hepatocellular Carcinoma

Heegon Kim, Bongseo Choi, Samdeep K Mouli, Hyunjun Choi, Kathleen R Harris, Laura M Kulik, Robert J Lewandowski, Dong-Hyun Kim iD

Advanced Healthcare Materials · 2023-10 · 12 (26)

DOI: 10.1002/adhm.202300906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.05.2023. Verfasst von Heegon Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein a practical strategy for augmenting immune activation in transcatheter arterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) is presented. Pluronic F127 (PF127) is incorporated with Lipiodol (LPD) to achieve safe and effective delivery of therapeutic agents during transcatheter intra‐arterial (IA) local delivery. Enhanced emulsion stability, IA infusion, embolic effect, safety, pharmacokinetics, and tumor response of Doxorubicin loaded PF127‐LPD (Dox‐PF127‐LPD) for TACE in both in vitro and in vivo preclinical VX2 liver cancer rabbit model and N1S1 HCC rat model are demonstrated. Then, transcatheter arterial chemo‐immuno‐embolization (TACIE) combining TACE and local delivery of immune adjuvant (TLR9 agonist CpG oligodeoxynucleotide) is successfully performed using CpG‐loaded Dox‐PF127‐LPD. Concurrent and safe local delivery of CpG and TACE during TACIE demonstrate leveraged TACE‐induced immunogenic tumor microenvironment and augment systemic anti‐tumor immunity in syngeneic N1S1 HCC rat model. Finally, the broad utility and enhanced therapeutic efficacy of TACIE are validated in the diethylnitrosamine‐induced rat HCC model. TACIE using clinically established protocols and materials shall be a convenient and powerful therapeutic approach that can be translated to patients with HCC. The robust anti‐cancer immunity and tumor regression of TACIE, along with its favorable safety profile, indicate its potential as a novel localized combination immunotherapy for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticHumansRatsAnimalsRabbitsEmulsionsTemperatureEthiodized OilDoxorubicinTreatment OutcomeTumor Microenvironment

Stichwörter der Autor:innen

hepatocellular carcinomaimmunotherapiesinterventional oncologylocal therapiestranscatheter arterial chemoembolization

Substanzen

EmulsionsEthiodized OilDoxorubicin

Autor:innen und Institutionen

  • Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
  • Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, 60611, USA.
  • Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.
  • Department of Biomedical Engineering, McCormick School of Engineering, Evanston, IL, 60208, USA.

ORCID-Profile: Dong-Hyun Kim

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • National Cancer Institute
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Kim, H., Choi, B., Mouli, S. K., Choi, H., Harris, K. R., Kulik, L. M., Lewandowski, R. J., & Kim, D. H. (2023). Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo‐Immuno‐Embolization for the Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials, 12(26). https://doi.org/10.1002/adhm.202300906

Vancouver

Kim H, Choi B, Mouli SK, Choi H, Harris KR, Kulik LM, et al. Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo‐Immuno‐Embolization for the Treatment of Hepatocellular Carcinoma. Advanced Healthcare Materials. 2023;12(26). doi:10.1002/adhm.202300906

BibTeX
@article{Kim2023,
  author = {Kim, Heegon and Choi, Bongseo and Mouli, Samdeep K and Choi, Hyunjun and Harris, Kathleen R and Kulik, Laura M and Lewandowski, Robert J and Kim, Dong-Hyun},
  title = {Preclinical Development and Validation of Translational Temperature Sensitive Iodized Oil Emulsion Mediated Transcatheter Arterial Chemo‐Immuno‐Embolization for the Treatment of Hepatocellular Carcinoma},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  volume = {12},
  number = {26},
  doi = {10.1002/adhm.202300906}
}
Kostenlos starten →